ORPHELIA Pharma will participate to the 14th annual conference of The European Paediatric Formulation Initiative (EuPFI) to be held from September 20-22 in Rome, Italy. This annual meeting aims to gather industry, academia, clinical and regulatory professionals, to share expertise and interactive discussions on development of paediatric formulations.
We are glad to announce that Caroline Lemarchand, Chief Pharmaceutical Development Officer at ORPHELIA Pharma, will attend this event and present the following session: “Formulation and assessment of Kimozo® an oral liquid formulation of temozolomide usable in children as young as 1 year old”. If you would like to meet Caroline, please contact her : caroline.lemarchand@orphelia-pharm.eu.